These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12817766)

  • 1. Ethical issues in the design of osteoporosis clinical trials: the state of the question.
    Heaney RP
    J Bone Miner Res; 2003 Jun; 18(6):1117-20. PubMed ID: 12817766
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical issues in clinical research on fracture prevention in patients with osteoporosis.
    Fost N
    J Bone Miner Res; 2003 Jun; 18(6):1110-5. PubMed ID: 12817765
    [No Abstract]   [Full Text] [Related]  

  • 3. Study designs in osteoporosis.
    Temple RJ
    J Bone Miner Res; 2003 Jun; 18(6):1129-32. PubMed ID: 12817769
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
    Brody BA; Dickey N; Ellenberg SS; Heaney RP; Levine RJ; O'Brien RL; Purtilo RB; Weijer C
    J Bone Miner Res; 2003 Jun; 18(6):1105-9. PubMed ID: 12817764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo controls in clinical trials of new therapies for osteoporosis.
    Levine RJ
    J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoride in the prevention of osteoporosis and fractures.
    Melton LJ
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S163-7. PubMed ID: 2187324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective.
    Rosenblatt M
    J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study design in osteoporosis: a European perspective.
    Kanis JA; Alexandre JM; Bone HG; Abadie E; Brasseur D; Chassany O; Durrleman S; Lekkerkerker JF; Caulin F
    J Bone Miner Res; 2003 Jun; 18(6):1133-8. PubMed ID: 12817770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surrogates for fracture endpoints in clinical trials.
    Khosla S
    J Bone Miner Res; 2003 Jun; 18(6):1146-9. PubMed ID: 12817773
    [No Abstract]   [Full Text] [Related]  

  • 10. Can underpowered clinical trials be justified?
    Rosoff PM
    IRB; 2004; 26(3):16-9. PubMed ID: 15281196
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins and osteoporosis: a clinical review.
    Gonyeau MJ
    Pharmacotherapy; 2005 Feb; 25(2):228-43. PubMed ID: 15767237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues related to clinical trials outside the International Conference on Harmonization regions.
    Karbwang J; Torres C
    Future Med Chem; 2011 Sep; 3(12):1457-60. PubMed ID: 21882937
    [No Abstract]   [Full Text] [Related]  

  • 14. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Muizelaar JP
    Ned Tijdschr Geneeskd; 1999 May; 143(20):1063. PubMed ID: 10368734
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis panel summary.
    Capron A; Donaldson S; Raisz LG; Swift S
    J Bone Miner Res; 2003 Jun; 18(6):1160-2. PubMed ID: 12817776
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of bone loss after organ transplantation.
    Cohen A; Sambrook P; Shane E
    J Bone Miner Res; 2004 Dec; 19(12):1919-32. PubMed ID: 15537434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF).
    Silverman SL; Cummings SR; Watts NB;
    J Bone Miner Res; 2008 Jan; 23(1):159-65. PubMed ID: 17892379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in designing and testing a "cure" for osteoporosis.
    Cummings S
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):408. PubMed ID: 15758283
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of osteoporotic fractures].
    Kannus P
    Duodecim; 1999; 115(7):759-64. PubMed ID: 11859509
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethical issues arising from medical research.
    Hamilton MP
    Isr J Med Sci; 1983 May; 19(5):431-6. PubMed ID: 6345463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.